Palantir Technologies (NASDAQ:PLTR – Get Free Report) had its target price hoisted by equities researchers at Royal Bank of Canada from $11.00 to $40.00 in a report issued on Tuesday,Benzinga reports.

Analysts at DA Davidson issued their Q1 2025 EPS estimates for shares of Cullen/Frost Bankers in a report issued on Tuesday, ...

Thomas J. Klima, the Chief Commercial and Operating Officer of bluebird bio, Inc. (NASDAQ:BLUE), recently sold shares of the company’s common stock. According to a recent SEC filing, Klima disposed of ...

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

Highlights,RBC Bearings saw increased holdings from institutional entities, highlighting market engagement.,Financial results ...